Skip to main content
Livermore
Livermore
ZHEN

Beam Therapeutics Inc.

BEAM
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001745999

In the last 90 days, Beam Therapeutics Inc. insiders filed 0 open-market purchases and 1 sale; 277 institutions reported holding it in 13F filings for Q2 2026, worth $3.75B in total; superinvestors ARK Invest and Duquesne Family Office hold it.

Q3 2024 vs. Q2 2024

How the institutions holding Beam Therapeutics Inc. changed between Q2 2024 and Q3 2024.

All holders in Q3 2024All holders in Q2 2024

13F holders of BEAM: Q2 2024 compared with Q3 2024
MeasureQ2 2024Of which not filed for Q3 2024Q3 2024Change
Holders2142221+9
Shares77.6M7.65M79.0M+9.10M (+13.0%)
Value$1.82B$179.3M$1.94B+$298.7M (+18.2%)

2 institutions that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (28)

Institutions that held Beam Therapeutics Inc. at the end of Q3 2024 but not at the end of Q2 2024.

Institutions new to BEAM in Q3 2024
InstitutionSharesValue% of portfolio
BlackRock, Inc.7,748,264$189.8M0.00%
Kynam Capital Management, LP1,302,085$31.9M2.47%
Logos Global Management LP500,000$12.3M1.37%
International Assets Investment Management, LLC64,313$2.63M0.01%
Twinbeech Capital LP58,208$1.43M0.03%
Jump Financial, LLC43,099$1.06M0.02%
Intech Investment Management LLC20,892$511.9K0.01%
Polar Asset Management Partners Inc.20,800$509.6K0.01%
DnB Asset Management AS20,799$509.6K0.00%
Crestline Management, LP17,415$426.7K0.02%
Franklin Resources Inc15,038$399.9K0.00%
Verition Fund Management LLC15,024$368.1K0.00%
Engineers Gate Manager LP15,006$367.6K0.01%
Prudential Financial Inc14,089$345.2K0.00%
Brandywine Managers, LLC11,306$277.0K0.30%
Stifel Financial Corp10,686$261.8K0.00%
Cambridge Investment Research Advisors, Inc.10,435$256.0K0.00%
Atria Investments LLC8,167$200.1K0.00%
Arcadia Investment Management Corp4,000$98.0K0.02%
Sterling Capital Management LLC263$6.44K0.00%
Golden State Equity Partners260$6.37K0.00%
Legacy Investment Solutions, LLC115$3.16K0.00%
Legacy Wealth Managment, LLC115$3.16K0.00%
Meeder Asset Management Inc118$2.89K0.00%
AdvisorNet Financial, Inc45$1.10K0.00%
Bessemer Group Inc35$1.00K0.00%
Northwestern Mutual Wealth Management Co24$5880.00%
Hemington Wealth Management6$00.00%

Sold out (19)

Institutions that held Beam Therapeutics Inc. at the end of Q2 2024 and filed for Q3 2024 without it.

Institutions that sold out of BEAM in Q3 2024
InstitutionShares, Q2 2024Value, Q2 2024
Ameriprise Financial Inc230,172$5.39M
Qube Research & Technologies Ltd102,359$2.40M
Jacobs Levy Equity Management, Inc41,076$962.4K
Eisler Capital (US) LLC34,378$805.5K
Los Angeles Capital Management LLC16,787$393.3K
Bridgefront Capital, LLC13,755$322.3K
Simplex Trading, LLC12,417$290.0K
Principal Financial Group Inc10,400$243.7K
Fishman Jay A Ltd10,000$234.3K
Squarepoint Ops LLC9,314$218.2K
Occudo Quantitative Strategies LP8,800$206.2K
D. E. Shaw & Co., Inc.8,721$204.3K
Aquatic Capital Management LLC6,100$142.9K
National Bank of Canada3,000$69.2K
Pacer Advisors, Inc.940$22.0K
Innealta Capital, LLC239$5.60K
RFP Financial Group LLC170$3.98K
Redwood Wealth Management Group, LLC90$2.11K
Piscataqua Savings Bank50$1.17K

Not filed for Q3 2024 yet (2)

Institutions that held Beam Therapeutics Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding BEAM in Q2 2024 that haven't filed for Q3 2024
InstitutionShares, Q2 2024Value, Q2 2024
BlackRock Inc.7,634,379$178.9M
Benjamin F. Edwards & Company, Inc.18,982$445.0K